News
The first participant has been dosed in Foresee's Phase 2 trial testing the experimental oral therapy mirivadelgat in people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback